ifosfamide has been researched along with Extranodal NK-T-Cell Lymphoma in 41 studies
Excerpt | Relevance | Reference |
---|---|---|
"Patients having rheumatoid arthritis (RA) treated with methotrexate (MTX) are at an increased risk of developing lymphoproliferative disorder (LPD)." | 3.81 | Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs. ( Fukayama, M; Koda, K; Tajima, S; Takanashi, Y, 2015) |
"The aim of this study was to compare asparaginase-related toxicities in two asparaginase preparations, namely native Escherichia coli L-asparaginase (L-ASP) and pegylated asparaginase (PEG-ASP) in combination with ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) in natural killer (NK)/T-cell lymphoma (NTCL)." | 1.48 | Comparison of Native Escherichia coli L-Asparaginase versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone, in Extranodal NK/T-Cell Lymphoma, Nasal Type. ( Cho, YS; Heo, DS; Jung, SH; Keam, B; Kim, DW; Kim, HJ; Kim, IH; Kim, M; Kim, TM; Lee, JY; Lee, SH; Ock, CY, 2018) |
"However, some patients experience early disease progression." | 1.48 | Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy. ( Amaki, J; Asano, N; Choi, I; Ejima, Y; Fukuhara, N; Katayama, N; Kim, SJ; Kim, WS; Ko, YH; Kobayashi, Y; Kubota, N; Maeda, T; Miyazaki, K; Oguchi, M; Saito, B; Shimada, K; Shimoda, E; Soejima, T; Suzuki, R; Terui, Y; Tsukamoto, N; Utsumi, T; Yamaguchi, M, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (17.07) | 29.6817 |
2010's | 29 (70.73) | 24.3611 |
2020's | 5 (12.20) | 2.80 |
Authors | Studies |
---|---|
Miyazaki, K | 4 |
Suzuki, R | 8 |
Oguchi, M | 5 |
Taguchi, S | 1 |
Amaki, J | 4 |
Maeda, T | 4 |
Kubota, N | 4 |
Maruyama, D | 2 |
Terui, Y | 2 |
Sekiguchi, N | 3 |
Takizawa, J | 4 |
Tsukamoto, H | 1 |
Murayama, T | 2 |
Ando, T | 3 |
Matsuoka, H | 2 |
Hasegawa, M | 2 |
Wada, H | 3 |
Sakai, R | 2 |
Kameoka, Y | 2 |
Tsukamoto, N | 2 |
Choi, I | 2 |
Masaki, Y | 2 |
Shimada, K | 2 |
Fukuhara, N | 2 |
Utsumi, T | 2 |
Uoshima, N | 1 |
Kagami, Y | 2 |
Asano, N | 4 |
Ejima, Y | 3 |
Katayama, N | 4 |
Yamaguchi, M | 9 |
Fujii, T | 1 |
Ohno, N | 1 |
Kitahara, S | 1 |
Kobayashi, S | 1 |
Sahara, N | 1 |
Sakamoto, N | 1 |
Arahira, S | 1 |
Matsunaga, T | 1 |
Sánchez-Romero, C | 1 |
Paes de Almeida, O | 1 |
Díaz Molina, JP | 1 |
Carlos, R | 1 |
Wei, L | 1 |
Wang, L | 1 |
Cong, J | 1 |
Yang, L | 1 |
Ye, J | 1 |
Li, X | 2 |
Yao, N | 1 |
Yang, J | 2 |
Wang, J | 2 |
Ghione, P | 1 |
Qi, S | 1 |
Imber, BS | 1 |
Seshan, V | 1 |
Moskowitz, A | 1 |
Galasso, N | 1 |
Lunning, M | 1 |
Straus, D | 1 |
Sauter, C | 1 |
Dahi, P | 1 |
Dogan, A | 1 |
Yahalom, J | 1 |
Horwitz, S | 1 |
Kim, HJ | 1 |
Ock, CY | 1 |
Kim, TM | 2 |
Lee, SH | 2 |
Lee, JY | 1 |
Jung, SH | 1 |
Cho, YS | 1 |
Kim, M | 2 |
Keam, B | 2 |
Kim, DW | 3 |
Kim, IH | 1 |
Heo, DS | 3 |
Kim, SJ | 7 |
Ko, YH | 5 |
Kobayashi, Y | 4 |
Soejima, T | 1 |
Saito, B | 3 |
Shimoda, E | 1 |
Kim, WS | 8 |
Watanabe, J | 1 |
Makita, S | 1 |
Ito, Y | 2 |
Hatta, S | 1 |
Suzuki, T | 2 |
Yuda, S | 1 |
Maeshima, AM | 1 |
Fukuhara, S | 1 |
Munakata, W | 1 |
Kim, SW | 1 |
Izutsu, K | 3 |
Kinoshita, S | 1 |
Tomita, N | 2 |
Niitsu, N | 1 |
Hildyard, C | 1 |
Sheikh, S | 1 |
Eyre, T | 1 |
Collins, G | 1 |
So, JC | 1 |
Chan, KH | 1 |
Pang, AW | 1 |
Chan, JK | 1 |
Kwong, YL | 3 |
Saburi, M | 1 |
Itani, K | 1 |
Nagamatsu, K | 1 |
Miyazaki, Y | 1 |
Otsuka, E | 1 |
Urabe, S | 1 |
Saburi, Y | 1 |
Ji, J | 1 |
Liu, T | 1 |
Xiang, B | 1 |
Liu, W | 1 |
He, C | 1 |
Chen, X | 1 |
Li, J | 1 |
Chang, H | 1 |
Dai, Y | 1 |
Dong, T | 1 |
Park, S | 2 |
Kang, ES | 2 |
Choi, JY | 1 |
Lim, DH | 1 |
Kim, KH | 1 |
Lee, JS | 1 |
Jeon, YK | 1 |
Kim, CW | 2 |
Shi, Y | 1 |
He, X | 1 |
Dong, M | 1 |
Zhang, C | 1 |
Liu, P | 1 |
Zhou, S | 1 |
Qin, Y | 1 |
Gui, L | 1 |
Yang, S | 1 |
Sun, Y | 1 |
Tajima, S | 1 |
Takanashi, Y | 1 |
Koda, K | 1 |
Fukayama, M | 1 |
Oh, D | 1 |
Ahn, YC | 2 |
Dong, LH | 1 |
Zhang, LJ | 1 |
Wang, WJ | 1 |
Lei, W | 1 |
Sun, X | 1 |
Du, JW | 1 |
Gao, X | 1 |
Li, GP | 1 |
Li, YF | 1 |
McEachron, TA | 1 |
Kirov, I | 1 |
Wungwattana, M | 1 |
Cortes, D | 1 |
Zabokrtsky, KB | 1 |
Sassoon, A | 1 |
Craig, D | 1 |
Carpten, JD | 1 |
Sender, LS | 1 |
Cui, Y | 1 |
Sun, Z | 1 |
Zhang, L | 1 |
Li, L | 1 |
Wang, X | 1 |
Wu, J | 1 |
Fu, X | 1 |
Ma, W | 1 |
Zhang, X | 1 |
Chang, Y | 1 |
Nan, F | 1 |
Li, W | 1 |
Su, L | 1 |
Xue, H | 1 |
Zhang, M | 1 |
Jung, KS | 1 |
Cho, SH | 1 |
Yoon, DH | 1 |
Jeong, SH | 1 |
Shin, DY | 1 |
Bae, SH | 1 |
Hong, J | 1 |
Park, SK | 1 |
Yhim, HY | 1 |
Yang, DH | 1 |
Lee, H | 1 |
Kang, HJ | 1 |
Lee, MH | 1 |
Eom, HS | 2 |
Kwak, JY | 1 |
Lee, JH | 1 |
Suh, C | 2 |
Al Shawabkeh, MA | 1 |
Al Sulaiti, M | 1 |
Al Sa'ey, H | 1 |
Ganesan, S | 1 |
Akiba, T | 1 |
Itasaka, S | 1 |
Saito, Y | 1 |
Itami, J | 1 |
Ueda, K | 1 |
Ii, N | 1 |
Hyo, R | 2 |
Celentano, A | 1 |
Mascolo, M | 1 |
Cirillo, N | 1 |
De Rosa, G | 1 |
Mignogna, MD | 1 |
Mizuno, H | 1 |
Koya, J | 1 |
Fujioka, Y | 1 |
Ibaraki, T | 1 |
Nakamura, F | 2 |
Hayashi, A | 1 |
Shinozaki-Ushiku, A | 1 |
Akamatsu, N | 1 |
Hasegawa, K | 1 |
Kokudo, N | 1 |
Fukuyama, M | 1 |
Kurokawa, M | 2 |
Kim, BS | 2 |
Im, SA | 1 |
Kim, TY | 1 |
Yoon, SS | 1 |
Bang, YJ | 1 |
Kim, BK | 1 |
Kim, NK | 1 |
Kato, T | 1 |
Tanabe, J | 1 |
Kanemoto, M | 1 |
Kobayashi, C | 1 |
Morita, S | 1 |
Karahashi, T | 1 |
Tobinai, K | 1 |
Ishizuka, N | 1 |
Isobe, Y | 2 |
Ishizawa, K | 1 |
Maseki, N | 1 |
Itoh, K | 1 |
Usui, N | 1 |
Wasada, I | 1 |
Kinoshita, T | 1 |
Ohshima, K | 1 |
Matsuno, Y | 1 |
Terauchi, T | 1 |
Nawano, S | 1 |
Ishikura, S | 1 |
Hotta, T | 1 |
Oshimi, K | 3 |
Kim, K | 1 |
Kim, CY | 1 |
Huh, J | 1 |
Lee, SW | 1 |
Kim, JS | 1 |
Cho, J | 1 |
Lee, GW | 1 |
Kang, KM | 1 |
Pyo, HR | 1 |
Inoue, D | 1 |
Nagai, Y | 1 |
Takiuchi, Y | 1 |
Nagano, S | 1 |
Arima, H | 1 |
Kimura, T | 1 |
Shimoji, S | 1 |
Mori, M | 1 |
Togami, K | 1 |
Tabata, S | 1 |
Yanagita, S | 1 |
Matsushita, A | 1 |
Nagai, K | 1 |
Maruoka, H | 1 |
Imai, Y | 2 |
Takahashi, T | 1 |
Farid, M | 1 |
Yau, YW | 1 |
Tay, K | 1 |
Quek, R | 1 |
Tao, M | 1 |
Koo, GC | 1 |
Loong, S | 1 |
Lim, ST | 2 |
Kimura, H | 1 |
Maeda, Y | 1 |
Hashimoto, C | 1 |
Ishida, F | 1 |
Fukushima, N | 1 |
Hasegawa, Y | 2 |
Kobayashi, H | 2 |
Okamura, S | 1 |
Suzumiya, J | 2 |
Nakamura, S | 2 |
Kawa, K | 2 |
Tang, T | 1 |
Tse, E | 1 |
Leung, AY | 1 |
Chim, CS | 1 |
Kobayashi, T | 1 |
Hangaishi, A | 1 |
Yamamoto, G | 1 |
Shinohara, A | 1 |
Morikawa, T | 1 |
Takazawa, Y | 1 |
Ota, S | 1 |
Okamura, T | 1 |
Wills, AJ | 1 |
O'Connor, S | 1 |
McMillan, A | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Randomized Controlled Multi-center Clinical Trial on Treatment of Stage Ⅲ/Ⅳ NK/T Cell Lymphoma With DDGP Regiment (Gemcitabine,Pegaspargase,Cisplatin,Dexamethasone)[NCT01501149] | Phase 4 | 80 participants (Anticipated) | Interventional | 2011-01-31 | Recruiting | ||
Efficacy and Safety of Brentuximab Vedotin in Combination With Tislelizumab for the Treatment of CD30-positive Relapsed/Refractory NK/T-cell Lymphoma[NCT05316246] | Phase 2 | 40 participants (Anticipated) | Interventional | 2022-06-01 | Not yet recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 reviews available for ifosfamide and Extranodal NK-T-Cell Lymphoma
Article | Year |
---|---|
[Treatment of localized nasal NK/T-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Combined Moda | 2008 |
Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; | 2010 |
Current and future management of NK/T-cell lymphoma based on clinical trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Chemoradiotherapy; Clinic | 2012 |
8 trials available for ifosfamide and Extranodal NK-T-Cell Lymphoma
Article | Year |
---|---|
Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi | 2019 |
DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; China; Cisplatin; D | 2016 |
Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemoradiotherapy; Cispla | 2016 |
Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Su | 2009 |
Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplati | 2009 |
Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Dexa | 2009 |
Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; DNA, Viral; E | 2012 |
Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone | 2008 |
30 other studies available for ifosfamide and Extranodal NK-T-Cell Lymphoma
Article | Year |
---|---|
Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Central Nervous System; D | 2022 |
[Extranodal NK/T cell lymphoma, nasal type with local recurrence in the contralateral nasal cavity 15 years after initial sequential chemoradiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemoradiotherapy; Female; Human | 2022 |
Pediatric nasal NK/T-cell lymphoma microscopically mimicking carcinoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma; Chemorad | 2020 |
SVILE regimen, a combination of dexamethasone, vindesine, ifosfamide, pegaspargase, and etoposide, for treating relapsed/refractory extranodal natural killer/T-cell lymphoma, nasal type.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone | 2020 |
Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Humans; Ifosfamide; Lym | 2020 |
Comparison of Native Escherichia coli L-Asparaginase versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone, in Extranodal NK/T-Cell Lymphoma, Nasal Type.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Escherichia coli; Etoposide; Fem | 2018 |
Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carbopla | 2018 |
Successful full-dose DeVIC therapy in a patient with advanced-stage extranodal natural killer/T-cell lymphoma refractory to L-asparaginase.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Dexamethasone; Drug Resis | 2018 |
Extranodal NK/T cell lymphoma, nasal type, presenting with meningeal infiltration in a Caucasian female.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Cerebrospinal Fluid | 2013 |
Diagnosis of brainstem involvement in NK/T cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Stem; Cerebrospinal Fluid; | 2014 |
[Successful treatment with high-dose methotrexate/cytarabine regimen in a patient in SMILE regimen-resistant extranodal natural killer/T-cell lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Dexamethasone; Drug | 2014 |
A study of gemcitabine, l-asparaginase, ifosfamide, dexamethasone and etoposide chemotherapy for newly diagnosed stage IV, relapsed or refractory extranodal natural killer/T-cell lymphoma, nasal type.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Deoxycytidine; Dexamethasone; Etoposid | 2014 |
Induction treatment with SMILE and consolidation with autologous stem cell transplantation for newly diagnosed stage IV extranodal natural killer/T-cell lymphoma patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cohort Studie | 2015 |
Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Etoposide; Fe | 2015 |
A pilot study of the safety and efficacy of dexamethasone, ifosfamide, methotrexate and gemcitabine chemotherapy for natural killer/T-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Dexamethason | 2015 |
Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs.
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Asparaginase; Diagnosis, Differential; Epstein-Barr Vi | 2015 |
Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparagine; Chemoradiotherapy; Cisplati | 2015 |
Sequential DICE combined with l-asparaginase chemotherapy followed by involved field radiation in newly diagnosed, stage IE to IIE, nasal and extranodal NK/T-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemoradiothe | 2016 |
Successful Treatment of Genetically Profiled Pediatric Extranodal NK/T-Cell Lymphoma Targeting Oncogenic STAT3 Mutation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemoradiotherapy; Child; Cytarabine; | 2016 |
L-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Moda | 2016 |
Nasal Type Extranodal Natural Killer/T (NK/T) Cell Lymphoma Presenting as Periorbital Cellulitis: A Case Report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Diagnosis, Differential; Etopo | 2016 |
Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi | 2017 |
Delayed Diagnosis of a Nasal Type Lymphoma Misdiagnosed as Persistent Sinusitis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chronic Disease; Delayed Diagno | 2017 |
Extranodal NK/T cell lymphoma in a living donor liver transplant recipient.
Topics: Allografts; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Drug Substi | 2017 |
A case of extranodal NK/T-cell lymphoma, nasal type mimicking typical manifestations of adult-onset Still's disease (AOSD) with hemophagocytic syndrome: diagnostic consideration between malignant lymphoma without lymphadenopathy and AOSD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Dexamethasone | 2009 |
Successful treatment of extranodal natural killer/T-cell lymphoma, nasal type, complicated by severe hemophagocytic syndrome, with dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide chemotherapy followed by autologous stem cell transpl
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemotherapy, Adjuvant; Combine | 2010 |
A promising new regimen for the treatment of advanced extranodal NK/T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Deoxycytidine; Fem | 2011 |
SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Clinic | 2012 |
Successful treatment of secondary NK/T-cell lymphoma of the testis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Dexame | 2013 |
Sub-acute demyelinating neuropathy associated with an NK/T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Cytarabine; Demyeli | 2008 |